Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Early Diagnosis of Pathogen Infection by Cell-Based Activation Immunoassay.

Bar-Haim E, Rotem S, Elia U, Bercovich-Kinori A, Israeli M, Cohen-Gihon I, Israeli O, Erez N, Achdout H, Zauberman A, Aftalion M, Mamroud E, Chitlaru T, Cohen O.

Cells. 2019 Aug 22;8(9). pii: E952. doi: 10.3390/cells8090952.

2.

Diagnosis of Imported Monkeypox, Israel, 2018.

Erez N, Achdout H, Milrot E, Schwartz Y, Wiener-Well Y, Paran N, Politi B, Tamir H, Israely T, Weiss S, Beth-Din A, Shifman O, Israeli O, Yitzhaki S, Shapira SC, Melamed S, Schwartz E.

Emerg Infect Dis. 2019 May;25(5):980-983. doi: 10.3201/eid2505.190076. Epub 2019 May 17.

3.

Differential Response Following Infection of Mouse CNS with Virulent and Attenuated Vaccinia Virus Strains.

Israely T, Paran N, Erez N, Cherry L, Tamir H, Achdout H, Politi B, Israeli O, Zaide G, Cohen-Gihon I, Vitner EB, Lustig S, Melamed S.

Vaccines (Basel). 2019 Feb 12;7(1). pii: E19. doi: 10.3390/vaccines7010019.

4.

Induction, treatment and prevention of eczema vaccinatum in atopic dermatitis mouse models.

Achdout H, Lustig S, Israely T, Erez N, Politi B, Tamir H, Israeli O, Waner T, Melamed S, Paran N.

Vaccine. 2017 Jul 24;35(33):4245-4254. doi: 10.1016/j.vaccine.2017.06.014. Epub 2017 Jun 20.

PMID:
28625523
5.

TLR3 and TLR9 agonists improve postexposure vaccination efficacy of live smallpox vaccines.

Israely T, Melamed S, Achdout H, Erez N, Politi B, Waner T, Lustig S, Paran N.

PLoS One. 2014 Oct 28;9(10):e110545. doi: 10.1371/journal.pone.0110545. eCollection 2014.

6.

Neuraminidase-mediated, NKp46-dependent immune-evasion mechanism of influenza viruses.

Bar-On Y, Glasner A, Meningher T, Achdout H, Gur C, Lankry D, Vitenshtein A, Meyers AFA, Mandelboim M, Mandelboim O.

Cell Rep. 2013 Apr 25;3(4):1044-50. doi: 10.1016/j.celrep.2013.03.034. Epub 2013 Apr 18.

7.

Loss of kindlin-3 alters the threshold for NK cell activation in human leukocyte adhesion deficiency-III.

Gruda R, Brown AC, Grabovsky V, Mizrahi S, Gur C, Feigelson SW, Achdout H, Bar-On Y, Alon R, Aker M, Davis DM, Mandelboim O.

Blood. 2012 Nov 8;120(19):3915-24. doi: 10.1182/blood-2012-02-410795. Epub 2012 Sep 14.

8.

Direct recognition of Fusobacterium nucleatum by the NK cell natural cytotoxicity receptor NKp46 aggravates periodontal disease.

Chaushu S, Wilensky A, Gur C, Shapira L, Elboim M, Halftek G, Polak D, Achdout H, Bachrach G, Mandelboim O.

PLoS Pathog. 2012;8(3):e1002601. doi: 10.1371/journal.ppat.1002601. Epub 2012 Mar 22.

9.

Recognition and killing of human and murine pancreatic beta cells by the NK receptor NKp46.

Gur C, Enk J, Kassem SA, Suissa Y, Magenheim J, Stolovich-Rain M, Nir T, Achdout H, Glaser B, Shapiro J, Naparstek Y, Porgador A, Dor Y, Mandelboim O.

J Immunol. 2011 Sep 15;187(6):3096-103. doi: 10.4049/jimmunol.1101269. Epub 2011 Aug 17.

10.

NKp46 O-glycan sequences that are involved in the interaction with hemagglutinin type 1 of influenza virus.

Mendelson M, Tekoah Y, Zilka A, Gershoni-Yahalom O, Gazit R, Achdout H, Bovin NV, Meningher T, Mandelboim M, Mandelboim O, David A, Porgador A.

J Virol. 2010 Apr;84(8):3789-97. doi: 10.1128/JVI.01815-09. Epub 2010 Feb 10.

11.

Killing of avian and Swine influenza virus by natural killer cells.

Achdout H, Meningher T, Hirsh S, Glasner A, Bar-On Y, Gur C, Porgador A, Mendelson M, Mandelboim M, Mandelboim O.

J Virol. 2010 Apr;84(8):3993-4001. doi: 10.1128/JVI.02289-09. Epub 2010 Feb 3.

12.

The activating receptor NKp46 is essential for the development of type 1 diabetes.

Gur C, Porgador A, Elboim M, Gazit R, Mizrahi S, Stern-Ginossar N, Achdout H, Ghadially H, Dor Y, Nir T, Doviner V, Hershkovitz O, Mendelson M, Naparstek Y, Mandelboim O.

Nat Immunol. 2010 Feb;11(2):121-8. doi: 10.1038/ni.1834. Epub 2009 Dec 20.

PMID:
20023661
13.

The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity.

Stanietsky N, Simic H, Arapovic J, Toporik A, Levy O, Novik A, Levine Z, Beiman M, Dassa L, Achdout H, Stern-Ginossar N, Tsukerman P, Jonjic S, Mandelboim O.

Proc Natl Acad Sci U S A. 2009 Oct 20;106(42):17858-63. doi: 10.1073/pnas.0903474106. Epub 2009 Oct 7.

14.

Enhanced in vivo growth of lymphoma tumors in the absence of the NK-activating receptor NKp46/NCR1.

Halfteck GG, Elboim M, Gur C, Achdout H, Ghadially H, Mandelboim O.

J Immunol. 2009 Feb 15;182(4):2221-30. doi: 10.4049/jimmunol.0801878.

15.

Influenza virus infection augments NK cell inhibition through reorganization of major histocompatibility complex class I proteins.

Achdout H, Manaster I, Mandelboim O.

J Virol. 2008 Aug;82(16):8030-7. doi: 10.1128/JVI.00870-08. Epub 2008 Jun 4.

16.

H5-type influenza virus hemagglutinin is functionally recognized by the natural killer-activating receptor NKp44.

Ho JW, Hershkovitz O, Peiris M, Zilka A, Bar-Ilan A, Nal B, Chu K, Kudelko M, Kam YW, Achdout H, Mandelboim M, Altmeyer R, Mandelboim O, Bruzzone R, Porgador A.

J Virol. 2008 Feb;82(4):2028-32. Epub 2007 Dec 12.

17.

Intercellular transfer of carcinoembryonic antigen from tumor cells to NK cells.

Stern-Ginossar N, Nedvetzki S, Markel G, Gazit R, Betser-Cohen G, Achdout H, Aker M, Blumberg RS, Davis DM, Appelmelk B, Mandelboim O.

J Immunol. 2007 Oct 1;179(7):4424-34.

18.

Intracellular cysteine residues in the tail of MHC class I proteins are crucial for extracellular recognition by leukocyte Ig-like receptor 1.

Gruda R, Achdout H, Stern-Ginossar N, Gazit R, Betser-Cohen G, Manaster I, Katz G, Gonen-Gross T, Tirosh B, Mandelboim O.

J Immunol. 2007 Sep 15;179(6):3655-61.

19.

NK cytotoxicity mediated by CD16 but not by NKp30 is functional in Griscelli syndrome.

Gazit R, Aker M, Elboim M, Achdout H, Katz G, Wolf DG, Katzav S, Mandelboim O.

Blood. 2007 May 15;109(10):4306-12. Epub 2007 Jan 25.

20.

Reduced KIR2DL1 recognition of MHC class I molecules presenting phosphorylated peptides.

Betser-Cohen G, Katz G, Gonen-Gross T, Stern N, Arnon TI, Achdout H, Gazit R, Mandelboim O.

J Immunol. 2006 Jun 1;176(11):6762-9.

21.

Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1.

Gazit R, Gruda R, Elboim M, Arnon TI, Katz G, Achdout H, Hanna J, Qimron U, Landau G, Greenbaum E, Zakay-Rones Z, Porgador A, Mandelboim O.

Nat Immunol. 2006 May;7(5):517-23. Epub 2006 Mar 26.

PMID:
16565719
22.

The CD85J/leukocyte inhibitory receptor-1 distinguishes between conformed and beta 2-microglobulin-free HLA-G molecules.

Gonen-Gross T, Achdout H, Arnon TI, Gazit R, Stern N, Horejsí V, Goldman-Wohl D, Yagel S, Mandelboim O.

J Immunol. 2005 Oct 15;175(8):4866-74.

23.

The involvement of NK cells in ankylosing spondylitis.

Azuz-Lieberman N, Markel G, Mizrahi S, Gazit R, Hanna J, Achdout H, Gruda R, Katz G, Arnon TI, Battat S, Zamir E, Adawi M, Mader R, Mandelboim O.

Int Immunol. 2005 Jul;17(7):837-45. Epub 2005 Jun 3.

PMID:
15937057
24.

Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus.

Arnon TI, Achdout H, Levi O, Markel G, Saleh N, Katz G, Gazit R, Gonen-Gross T, Hanna J, Nahari E, Porgador A, Honigman A, Plachter B, Mevorach D, Wolf DG, Mandelboim O.

Nat Immunol. 2005 May;6(5):515-23. Epub 2005 Apr 10.

PMID:
15821739
25.

The critical role of residues 43R and 44Q of carcinoembryonic antigen cell adhesion molecules-1 in the protection from killing by human NK cells.

Markel G, Gruda R, Achdout H, Katz G, Nechama M, Blumberg RS, Kammerer R, Zimmermann W, Mandelboim O.

J Immunol. 2004 Sep 15;173(6):3732-9.

26.

MHC class I-independent recognition of NK-activating receptor KIR2DS4.

Katz G, Gazit R, Arnon TI, Gonen-Gross T, Tarcic G, Markel G, Gruda R, Achdout H, Drize O, Merims S, Mandelboim O.

J Immunol. 2004 Aug 1;173(3):1819-25.

27.

Biological function of the soluble CEACAM1 protein and implications in TAP2-deficient patients.

Markel G, Achdout H, Katz G, Ling KL, Salio M, Gruda R, Gazit R, Mizrahi S, Hanna J, Gonen-Gross T, Arnon TI, Lieberman N, Stren N, Nachmias B, Blumberg RS, Steuer G, Blau H, Cerundolo V, Mussaffi H, Mandelboim O.

Eur J Immunol. 2004 Aug;34(8):2138-48.

28.

Recognition of Mycoplasma hyorhinis by CD99-Fc molecule.

Gazit R, Rechnitzer H, Achdout H, Katzenell A, Katz G, Markel G, Arnon TI, Gonen-Gross T, Mizrahi S, Gruda R, Rottem S, Mandelboim O.

Eur J Immunol. 2004 Jul;34(7):2032-40.

29.

Expression of KIR2DL1 on the entire NK cell population: a possible novel immunodeficiency syndrome.

Gazit R, Garty BZ, Monselise Y, Hoffer V, Finkelstein Y, Markel G, Katz G, Hanna J, Achdout H, Gruda R, Gonen-Gross T, Mandelboim O.

Blood. 2004 Mar 1;103(5):1965-6. No abstract available.

30.

The mechanisms controlling NK cell autoreactivity in TAP2-deficient patients.

Markel G, Mussaffi H, Ling KL, Salio M, Gadola S, Steuer G, Blau H, Achdout H, de Miguel M, Gonen-Gross T, Hanna J, Arnon TI, Qimron U, Volovitz I, Eisenbach L, Blumberg RS, Porgador A, Cerundolo V, Mandelboim O.

Blood. 2004 Mar 1;103(5):1770-8. Epub 2003 Nov 6. Erratum in: Blood. 2015 Mar 19;125(12):2006.

31.

Special organization of the HLA-G protein on the cell surface.

Gonen-Gross T, Gazit R, Achdout H, Hanna J, Mizrahi S, Markel G, Horejsí V, Mandelboim O.

Hum Immunol. 2003 Nov;64(11):1011-6.

PMID:
14602229
32.

The mechanisms controlling the recognition of tumor- and virus-infected cells by NKp46.

Arnon TI, Achdout H, Lieberman N, Gazit R, Gonen-Gross T, Katz G, Bar-Ilan A, Bloushtain N, Lev M, Joseph A, Kedar E, Porgador A, Mandelboim O.

Blood. 2004 Jan 15;103(2):664-72. Epub 2003 Sep 22.

33.

Complexes of HLA-G protein on the cell surface are important for leukocyte Ig-like receptor-1 function.

Gonen-Gross T, Achdout H, Gazit R, Hanna J, Mizrahi S, Markel G, Goldman-Wohl D, Yagel S, Horejsí V, Levy O, Baniyash M, Mandelboim O.

J Immunol. 2003 Aug 1;171(3):1343-51.

34.

Enhanced recognition of human NK receptors after influenza virus infection.

Achdout H, Arnon TI, Markel G, Gonen-Gross T, Katz G, Lieberman N, Gazit R, Joseph A, Kedar E, Mandelboim O.

J Immunol. 2003 Jul 15;171(2):915-23.

Supplemental Content

Loading ...
Support Center